Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-IVF Treatment With a GnRH Antagonist in Women With Endometriosis
NCT04173169Phase 3Completed
- Sponsor
- Yale University
- Start
- Mar 2022
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of elagolix in endometriosis, infertility, sponsored by Yale University. Started Mar 2022; status: completed.
02
Drugs
elagolix
03
Conditions
endometriosisinfertility
Beyond the preview
Go deeper on NCT04173169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04173169.